Iodine-based contrast media, multiple myeloma and monoclonal gammopathies: literature review and ESUR Contrast Media

Fulvio Stacul1, Michele Bertolotto2, Henrik S Thomsen3

  • 1S.C. Radiologia Ospedale Maggiore, Piazza Ospitale 1, IT-34129, Trieste, Italy.

European Radiology
|September 1, 2017
PubMed
Abstract

Insights

Multiple myeloma and monoclonal gammopathies do not increase the risk of post-contrast acute kidney injury (PC-AKI) in patients with normal renal function. However, dehydration and hypercalcemia in these patients can elevate PC-AKI risk.

Area of Science:

  • Nephrology
  • Radiology
  • Oncology

Background:

  • Multiple myeloma (MM) and monoclonal gammopathies (MG) are often considered contraindications for iodine-based contrast media due to perceived risks of kidney injury.
  • Radiologists and clinicians frequently avoid contrast media in these patient populations.

Purpose of the Study:

  • To systematically review the incidence of post-contrast acute kidney injury (PC-AKI) in patients with MM or MG.
  • To evaluate the actual risk of PC-AKI associated with iodine-based contrast media in these specific patient groups.

Main Methods:

  • A systematic literature search was conducted in Medline and Scopus databases.
  • Included studies were cohort and case-control studies reporting renal function changes after contrast administration, adhering to PRISMA guidelines.
  • Data collection and analysis followed pre-specified eligibility criteria.

Main Results:

  • Thirteen studies involving 824 contrast administrations in 642 patients with MM or MG were analyzed.
  • A low incidence of PC-AKI was observed, with only 12 unconfounded cases (1.6%).
  • Most administrations involved intravenous urography with high-osmolality contrast media in dehydrated patients.

Conclusions:

  • MM and MG alone are not independent risk factors for PC-AKI.
  • Dehydrated patients with impaired renal function and hypercalcemia face an increased risk of PC-AKI.
  • Correction of hypercalcemia is recommended prior to contrast administration; Bence-Jones proteinuria assessment is unnecessary.

Related Concept Videos